Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-24-000126
Filing Date
2024-08-05
Accepted
2024-08-05 16:35:15
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20240630.htm   iXBRL 10-Q 1591819
2 EX-10.1 bmrn-exx101xq22024.htm EX-10.1 14452
3 EX-10.2 bmrn-exx102xq2x2024.htm EX-10.2 13548
4 EX-31.1 bmrn-exx311xq22024.htm EX-31.1 9227
5 EX-31.2 bmrn-exx312xq22024.htm EX-31.2 9240
6 EX-32.1 bmrn-exx321xq22024.htm EX-32.1 5132
  Complete submission text file 0001048477-24-000126.txt   7677396

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20240630.xsd EX-101.SCH 45320
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20240630_cal.xml EX-101.CAL 74304
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20240630_def.xml EX-101.DEF 226310
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20240630_lab.xml EX-101.LAB 586340
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20240630_pre.xml EX-101.PRE 416707
82 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20240630_htm.xml XML 1262900
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 241175335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)